CYTK(Cytokinetics, Incorporated) · 财务报表

CYTK(Cytokinetics, Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$70.43M$94.59M$7.53M$18.47M$88.04M
毛利润—————
营业利润−$186.31M−$324.20M−$496.20M−$536.25M−$612.26M
净利润−$215.31M−$388.95M−$526.24M−$589.53M−$784.96M
经营现金流−$142.52M−$299.52M−$414.33M−$395.89M−$510.01M
自由现金流−$191.39M−$310.85M−$415.75M−$399.80M−$534.82M
摊薄每股收益$-2.80$-4.33$-5.45$-5.26$-6.54

Cytokinetics, Incorporated CYTK